Deferasirox Tablet, For Suspension
Product Images NDC 72205-391

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 72205-391). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Deferasirox-tabs-os-125-mg-30s-cntr-lbl (Deferasirox Tabs Os 125 mg 30s Cntr Lbl)

Deferasirox Tablets for Oral Suspension, 125 mg per tablet, in a bottle label showing a 30 tablet count. The label includes storage instructions (20°C to 25°C with permitted excursions), manufacturer (MSN Laboratories Private Limited, India), and distributor (Novadoz Pharmaceuticals LLC). It recommends tablets be dispersed in water or juice before ingestion and instructs pharmacists to provide a medication guide.*

FDA Label Image

Deferasirox-tabs-os-250-mg-30s-cntr-lbl (Deferasirox Tabs Os 250 mg 30s Cntr Lbl)

Label for Deferasirox Tablets for Oral Suspension, 250 mg per tablet, containing 30 tablets. The label includes storage instructions (206 to 256C), manufacturer (MSN Laboratories Private Limited, India), and distributor information (Novadoz Pharmaceuticals LLC). It advises not to chew or swallow whole and to disperse tablets in water or juice prior to ingestion.*

FDA Label Image

Deferasirox-tabs-os-500-mg-30s-cntr-lbl (Deferasirox Tabs Os 500 mg 30s Cntr Lbl)

Label for Deferasirox Tablets for Oral Suspension, 500 mg per tablet, in a package of 30 tablets. The label states not to chew or swallow whole and that tablets must be dispersed in water, orange, or apple juice before ingestion. Manufactured by MSN Laboratories Private Limited, India, and distributed by Novadoz Pharmaceuticals LLC.*

FDA Label Image

Deferasirox-tabs-os-figure-1 (Deferasirox Tabs Os Figure 1)

A bar chart showing the changes in liver iron content and serum ferritin levels at different doses of Deferasirox tablets measured in mg/kg/day. The x-axis represents Deferasirox dose (5, 10, 20, 30 mg/kg/day), and the y-axes display changes in liver iron content (mg Fe/g dry weight) and serum ferritin (mcg/L). Both variables fluctuate with increasing dose, with negative changes at the highest dose.*

FDA Label Image

Deferasirox-tabs-os-structure (Deferasirox Tabs Os Structure)

Chemical structure diagram of Deferasirox, showing its molecular framework with three hydroxyl groups attached to benzene rings and a triazole ring connecting them.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.